Edwyn O Cruz-López

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Hyaluronic Acid

Angiotensin Converting Enzyme

Top Venues

Hypertension (Dallas, Tex. : 1979)

Arteriosclerosis, thrombosis, and vascular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Edwyn O Cruz-López, Daphne Merkus, A H Jan Danser
Blood Pressure Monitoring Through Radiotelemetry: Exploring the Viability of Its Application in Multihoused Small Laboratory Animals. Hypertension (Dallas, Tex. : 1979) 81 (5) (2024)
Dien Ye, Edwyn O Cruz-López, Richard van Veghel, Ingrid M Garrelds, Anne Kasper, Kelly Wassarman, Ho-Chou Tu, Ivan Zlatev, A H Jan Danser
Counteracting Angiotensinogen Small-Interfering RNA-Mediated Antihypertensive Effects With REVERSIR. Hypertension (Dallas, Tex. : 1979) 81 (7) (2024)
Dien Ye, Edwyn O Cruz-López, Richard van Veghel, Ingrid M Garrelds, Anne Kasper, Kelly Wassarman, Ho-Chou Tu, Ivan Zlatev, A H Jan Danser
Counteracting Angiotensinogen Small-Interfering RNA-Mediated Antihypertensive Effects With REVERSIR. Hypertension (Dallas, Tex. : 1979) 81 (7) (2024)
Edwyn O Cruz-López, Daphne Merkus, A H Jan Danser
Blood Pressure Monitoring Through Radiotelemetry: Exploring the Viability of Its Application in Multihoused Small Laboratory Animals. Hypertension (Dallas, Tex. : 1979) 81 (5) (2024)
Dien Ye, Edwyn O Cruz-López, Richard van Veghel, Ingrid M Garrelds, Anne Kasper, Kelly Wassarman, Ho-Chou Tu, Ivan Zlatev, A H Jan Danser
Counteracting Angiotensinogen Small-Interfering RNA-Mediated Antihypertensive Effects With REVERSIR. Hypertension (Dallas, Tex. : 1979) 81 (7) (2024)
Dien Ye, Edwyn O Cruz-López, Richard van Veghel, Ingrid M Garrelds, Anne Kasper, Kelly Wassarman, Ho-Chou Tu, Ivan Zlatev, A H Jan Danser
Counteracting Angiotensinogen Small-Interfering RNA-Mediated Antihypertensive Effects With REVERSIR. Hypertension (Dallas, Tex. : 1979) 81 (7) (2024)
Dien Ye, Edwyn O Cruz-López, Ho-Chou Tu, Ivan Zlatev, Alexander H J Danser
Targeting Angiotensinogen With N -Acetylgalactosamine-Conjugated Small Interfering RNA to Reduce Blood Pressure. Arteriosclerosis, thrombosis, and vascular biology (2023)
Edwyn O Cruz-López, Dien Ye, Congqing Wu, Hong S Lu, Estrellita Uijl, Katrina M Mirabito Colafella, Alexander H J Danser
Angiotensinogen Suppression: A New Tool to Treat Cardiovascular and Renal Disease. Hypertension (Dallas, Tex. : 1979) 79 (10) (2022)